Jpmorgan Chase & CO Globus Medical Inc Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Globus Medical Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 2,635,851 shares of GMED stock, worth $186 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,635,851
Previous 2,112,103
24.8%
Holding current value
$186 Million
Previous $113 Million
59.35%
% of portfolio
0.02%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding GMED
# of Institutions
473Shares Held
111MCall Options Held
190KPut Options Held
50.5K-
Vanguard Group Inc Valley Forge, PA10.7MShares$754 Million0.01% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$730 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X07.38MShares$521 Million0.28% of portfolio
-
State Street Corp Boston, MA3.49MShares$246 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA3.21MShares$227 Million0.04% of portfolio
About GLOBUS MEDICAL INC
- Ticker GMED
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 77,037,200
- Market Cap $5.44B
- Description
- Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devi...